文献速递心血管外周血管OCT

斑块侵蚀与斑块破裂所致STEMI的全冠状动脉斑块特征:三血管OCT研究

Pancoronary Plaque Characteristics in STEMI Caused by Culprit Plaque Erosion Versus Rupture: 3-Vessel OCT Study.
PubMed 文献 · JACC Cardiovasc Imaging · 2020-10-28

本研究纳入2016年10月至2018年9月行三血管OCT的STEMI患者,比较 culprit 斑块侵蚀(PE)与斑块破裂(PR)患者非 culprit 斑块的易损性。结果显示PE患者非 culprit 高危斑块(CLIMA标准)比例低于PR患者(11.4% vs 25.2%,p<0.001),非 culprit 斑块破裂在PE(纤维型)中罕见(1.9%),提示PE患者全冠状动脉易损性有限。

要点

  • cuplrit PE患者非 culprit 高危斑块(CLIMA标准)占11.4%,低于 culprit PR患者的25.2%。
  • 非 culprit 斑块破裂在 culprit PE(纤维型)中仅1.9%,在PE(脂质丰富型)与PR中相近(16.3% vs 17.8%)。
  • FCT<75 μm、巨噬细胞及TCFA的患病率从PE(纤维型)到PE(脂质丰富型)到PR呈显著梯度。

核心结论

  • culprit PE的STEMI患者全冠状动脉易损性有限,可能解释其预后优于culprit PR患者。
  • culprit PE独立于传统危险因素预测全冠状动脉易损性降低。

研究设计与样本

  • 研究类型为三血管OCT观察性研究,纳入2016年10月至2018年9月行直接PCI时三血管OCT的523例患者,最终分析排除152例。
  • 最终分析纳入202例culprit PE的STEMI患者(458个非culprit斑块)和321例culprit PR的STEMI患者(1027个非culprit斑块)。
  • 高危斑块采用CLIMA研究(NCT02883088)标准:同时满足最小管腔面积<3.5 mm²、纤维帽厚度<75 μm、最大脂质弧>180º及巨噬细胞积聚4项OCT特征。

关键影像表现/征象

  • 至少1个CLIMA定义的OCT非culprit高危斑块见于11.4%的culprit PE患者,culprit PR患者为25.2%(p<0.001)。
  • 非culprit斑块破裂在culprit PE(纤维型)中占1.9%,在culprit PE(脂质丰富型)中占16.3%,在PR中占17.8%。
  • FCT<75 μm、巨噬细胞及TCFA的患病率从PE(纤维型)到PE(脂质丰富型)到PR呈显著梯度。
  • 单独分析各项高危特征时,culprit PR患者中这些特征的比例同样高于culprit PE患者。

诊断标准与关键数值

  • CLIMA定义的高危斑块需同时满足:最小管腔面积<3.5 mm²、纤维帽厚度<75 μm、最大脂质弧>180º、巨噬细胞积聚。
  • 非culprit高危斑块患病率:culprit PE患者11.4% vs culprit PR患者25.2%(p<0.001)。
  • 非culprit斑块破裂患病率:culprit PE(纤维型)1.9%,culprit PE(脂质丰富型)16.3%,culprit PR 17.8%。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: This study sought to investigate nonculprit plaque characteristics in patients with ST-segment elevation myocardial infarction (STEMI) presenting with plaque erosion (PE) and plaque rupture (PR). Pancoronary vulnerability was considered at nonculprit sites: 1) the CLIMA (Relationship Between OCT Coronary Plaque Morphology and Clinical Outcome) study (NCT02883088) defined high-risk plaques with simultaneous presence of 4 optical coherence tomography (OCT) features (minimum lumen area <3.5 mm2; fibrous cap thickness [FCT] <75 μm; maximum lipid arc >180º; and macrophage accumulation); and 2) the presence of plaque ruptures or thin-cap fibroatheromas (TCFA).

BACKGROUND: PE is a unique clinical entity associated with better outcomes than PR. There is limited evidence regarding pancoronary plaque characteristics of patients with culprit PE versus culprit PR.

METHODS: Between October 2016 and September 2018, 523 patients treated by 3-vessel OCT at the time of primary percutaneous intervention were included with 152 patients excluded from final analysis.

RESULTS: Overall, 458 nonculprit plaques were identified in 202 STEMI patients with culprit PE; and 1,027 nonculprit plaques were identified in 321 STEMI patients with culprit PR. At least 1 CLIMA-defined OCT nonculprit high-risk plaque was seen in 11.4% of patients with culprit PE, but twice as many patients were seen with culprit PR (25.2%; p < 0.001). This proportion was also seen when individual high-risk features were analyzed separately. When patients with PE were divided by a heterogeneous substrate (fibrous or lipid-rich plaque) underlying the culprit site, the prevalence of nonculprits with FCT <75 μm, macrophages, and TCFA showed a significant gradient from PE(Fibrous) to PElipid-rich plaque (LRP) to PR. Interestingly, nonculprit rupture was rarely found in patients with culprit PE(Fibrous) (1.9%), although it was exhibited with comparable prevalence in patients with culprit PE(LRP) (16.3%) versus PR (17.8%). Culprit PE predicted decreased pancoronary vulnerability independent of conventional risk factors.

CONCLUSIONS: STEMI patients with culprit PE have a limited pancoronary vulnerability that may explain better outcomes in these patients than in STEMI patients with culprit PR.

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Cao M, Zhao L, Ren X, et al. Pancoronary Plaque Characteristics in STEMI Caused by Culprit Plaque Erosion Versus Rupture: 3-Vessel OCT Study. JACC Cardiovasc Imaging. 2020. PMID: 33129735. doi:10.1016/j.jcmg.2020.07.047

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。